CJC-1295 with DAC (Drug Affinity Complex) is a long-acting modified analog of growth hormone-releasing hormone (GHRH) consisting of the 30-amino-acid Modified GRF (1-29) sequence conjugated to a maleimidopropionyl-Lys (MPA) lysine residue, with a molecular weight of approximately 3,647.9 Da. The DAC modification enables covalent binding to circulating serum albumin in research models, extending the apparent half-life of the peptide significantly compared to CJC-1295 without DAC. First described in published research in 2005, CJC-1295 with DAC is studied in endocrine research models that investigate sustained GHRH receptor activation. Also searched as CJC1295 DAC, CJC with DAC, or long-acting CJC-1295, it is supplied as a lyophilized powder for laboratory reference use. Triumphant Labs CJC-1295 with DAC is provided strictly for in vitro research applications and is not approved for human or animal use.

DISCLAIMER: By purchasing from Triumphant Labs you agree that you are purchasing Research Chemicals which are in no way intended for use in humans.

Triumphant Labs products are furnished for LABORATORY RESEARCH USE ONLY. This product should only be handled by qualified, and licensed professionals. The product may not be used as a drug, agricultural or pesticidal product, food additive or household chemical – and may not be misbranded as such. Bodily introduction of any kind into humans and/or animals is strictly forbidden by law.

Research Chemicals ARE NOT DIETARY SUPPLEMENTS OR PRESCRIPTION MEDICATIONS THEY ARE *RESEARCH CHEMICALS.

*Research chemicals are chemical substances used by scientists for medical and scientific research purposes. One characteristic of a research chemical is that it is for laboratory research use only; a research chemical is not intended for human or veterinary use. This distinction is required on the labels of research chemicals, and is what exempts them from regulation under parts 100-740 in Title 21 of the Code of Federal Regulations (21CFR).